Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (ISRCTN99737999) titled 'Topical alprostadil in patients with systemic sclerosis' on Oct. 22.
Study Type: Interventional
Study Design:
Single centre interventional blinded randomized controlled trial (Other)
Primary Sponsor: University of Manchester
Condition:
Systemic Sclerosis (SSc), scleroderma
Skin and Connective Tissue Diseases
Intervention:
Treatment: One off topical application of study drug, alprostadil cream, to one of the fingers of the participant's dominant hand.
Placebo: One off topical application of study placebo, Lipobase cream, to a second finger of the participants dominant hand.
No treatment: To a third finger o...